Works by van Bergen en Henegouwen, Paul M.P.


Results: 7
    1

    Preclinical targeting of liver fibrosis with a <sup>89</sup>Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 12, p. 3545, doi. 10.1007/s00259-024-06785-9
    By:
    • Muns, Joey A.;
    • Schooten, Erik;
    • van Dasselaar, Rychon D. J.;
    • Noordman, Yvet E.;
    • Adamzek, Kevin;
    • Eibergen, Arthur C.;
    • Pronk, Sebas D.;
    • Cali, Sagel;
    • Sijbrandi, Niels J.;
    • Merkul, Eugen;
    • Oliveira, Sabrina;
    • van Bergen en Henegouwen, Paul M.P.;
    • Takkenberg, R. Bart;
    • Verheij, Joanne;
    • van de Graaf, Stan F.J.;
    • Nijmeijer, Bart A.;
    • van Dongen, Guus A.M.S.
    Publication type:
    Article
    2
    3
    4

    A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

    Published in:
    International Journal of Cancer, 2011, v. 129, n. 8, p. 2013, doi. 10.1002/ijc.26145
    By:
    • Roovers, Rob C.;
    • Vosjan, Maria J.W.D.;
    • Laeremans, Toon;
    • el Khoulati, Rachid;
    • de Bruin, Renée C.G.;
    • Ferguson, Kathryn M.;
    • Verkleij, Arie J.;
    • van Dongen, Guus A.M.S.;
    • van Bergen en Henegouwen, Paul M.P.
    Publication type:
    Article
    5
    6
    7